China's official news agency hinted that more foreign pharmaceutical firms could soon be implicated in a corruption scandal sweeping the industry, in the wake of bribery accusations against British drug maker GlaxoSmithKline. Corruption in China's pharmaceutical industry is fuelled in part by the low base salaries for doctors at the country's 13,500 public hospitals.